NCT01830660View on ClinicalTrials.gov

A Phase I Study of Hetrombopag Olamine in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Healthy
Interventions
DRUG

Hetrombopag Olamine Tablets

DRUG

placebo

Trial Locations (1)

Unknown

West China Hospital, Sichuan University, Chengdu

All Listed Sponsors
lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT01830660 - A Phase I Study of Hetrombopag Olamine in Healthy Adult Volunteers | Biotech Hunter | Biotech Hunter